Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-10-14

Clinical Trial Update: Efficacy of Adding Dexmedetomidine as an Adjuvant to Bupivacaine in TAP Block and Caudal Block [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluation of adding dexmedetomidine to bupivacaine for TAP and caudal blocks in postoperative pain, currently in Phase 1/Phase 2 with unknown …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupivacaine (Bupivacaine)
  • Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Ain Shams University | Conditions: Pain, Postoperative | Phase 1, Phase 2 | Status: UNKNOWN